# Quetiapine Fumarate Bipolar Maintenance Monotherapy

> **NCT00314184** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1255 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** quetiapine fumarate

## Key facts

- **NCT ID:** NCT00314184
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 1255 (ACTUAL)
- **Last updated:** 2008-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314184, "Quetiapine Fumarate Bipolar Maintenance Monotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00314184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*